Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
Users Online: 260

 

Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Advertise Contacts Login 
     
ORIGINAL ARTICLE
Year : 2009  |  Volume : 50  |  Issue : 2  |  Page : 47-51

Maxillary ameloblastoma: An enigma for the surgeon


1 Maxillofacial Unit, Ahmadu Bello University Teaching Hospital Kaduna, Kaduna State, Nigeria
2 44 Nigerian Army Reference Hospital, Kaduna, Kaduna State, Nigeria
3 Radiology Department, Ahmadu Bello University Teaching Hospital, Kaduna, Kaduna State, Nigeria
4 Pathology Department, Ahmadu Bello University Teaching Hospital, Zaria, Kaduna, Kaduna State, Nigeria

Correspondence Address:
S O Ajike
Reader/Maxillofacial Surgeon, Ahmadu Bello University Teaching Hospital, Zaria, Kaduna
Nigeria
Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and Permissions

Background:Ameloblastoma is a benign but locally aggressive odontogenic tumour. Worldwide, maxillary ameloblastoma is rare but its late detection renders adequate treatment difficult. Majority occur in the mandible with about 5-20% occurring in the maxillary bone. Objective: The purpose of this study was to analyze 21 cases of maxillary ameloblastoma seen and managed at the Oral and Maxillofacial Unit of Ahmadu Bello University Teaching Hospital, Zaria, Nigeria and Alba Clinic and Medical Centre, Kaduna, Nigeria. Study Design:A retrospective study of cases of maxillary ameloblastoma from all cases of ameloblastoma seen from January 1993 to August 2008. Data with respect to patient's sex, age, tumour location, clinical presentation, radiologic features, biological and histopathologic type, surgical treatment and recurrences were analyzed. Results:Out of 350 cases of ameloblastoma seen within the period, 21(6%) Patients were with maxillary am eloblastoma. Of the 21 cases, there were 13 males and 8 females, a male female ratio of 1.6 to 1, with an age range of 17-55 years (mean = 38.14), peaking at the 4 th and 5 th decades of life (61.9%). Tumour duration was from 3 months to 14 years. There were 18 unilateral and 3 bilateral swellings. Clinically, maxillary ameloblastoma presented with grotesque swellings, with antral involvement in 19 cases, teeth mobility/exfoliation. Radiologically, there were 20 multilocular and 1 unilocular radiolucent lesions. The most common histopathologic type was follicular (11, 52.4%).there were 22 procedures done on 21 patients; 21 maxillectomies and 1 enucleation. Follow up period of 18 patients was between 3 months and 10 years from which 3(16.7%) recurrences were observed. Conclusion:Ameloblastum a is uncommon in the maxilla. While maxillary ameloblastoma is indistinguishable histologically from its mandibular counterpart, it is very lethal. An excellent result achieved in this study was due to the radical mode of treatment of the multilocular variety. Rehabilitation postoperatively remains a challenge. Periodic life-long follow-up is recommended.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed5609    
    Printed179    
    Emailed0    
    PDF Downloaded358    
    Comments [Add]    

Recommend this journal